Zivo Bioscience Inc (ZIVO)
7.99
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Zivo Bioscience Total Liabilities (Quarterly): 3.085M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.085M |
| December 31, 2023 | 2.762M |
| September 30, 2023 | 3.196M |
| June 30, 2023 | 3.855M |
| March 31, 2023 | 2.870M |
| December 31, 2022 | 2.134M |
| September 30, 2022 | 2.447M |
| June 30, 2022 | 2.854M |
| March 31, 2022 | 3.104M |
| December 31, 2021 | 2.948M |
| September 30, 2021 | 3.551M |
| June 30, 2021 | 3.771M |
| March 31, 2021 | 12.07M |
| December 31, 2020 | 11.53M |
| September 30, 2020 | 11.22M |
| June 30, 2020 | 10.22M |
| March 31, 2020 | 9.327M |
| December 31, 2019 | 8.708M |
| September 30, 2019 | 10.97M |
| June 30, 2019 | 11.27M |
| March 31, 2019 | 24.80M |
| December 31, 2018 | 22.69M |
| September 30, 2018 | 21.85M |
| June 30, 2018 | 19.58M |
| March 31, 2018 | 22.35M |
| Date | Value |
|---|---|
| December 31, 2017 | 16.64M |
| September 30, 2017 | 19.47M |
| June 30, 2017 | 16.78M |
| March 31, 2017 | 16.57M |
| December 31, 2016 | 14.36M |
| September 30, 2016 | 13.52M |
| June 30, 2016 | 11.21M |
| March 31, 2016 | 10.47M |
| December 31, 2015 | 9.570M |
| September 30, 2015 | 8.775M |
| June 30, 2015 | 8.074M |
| March 31, 2015 | 7.540M |
| December 31, 2014 | 6.471M |
| September 30, 2014 | 9.636M |
| June 30, 2014 | 6.548M |
| March 31, 2014 | 6.667M |
| December 31, 2013 | 11.77M |
| September 30, 2013 | 12.55M |
| June 30, 2013 | 9.107M |
| March 31, 2013 | 5.098M |
| December 31, 2012 | 4.190M |
| September 30, 2012 | 3.578M |
| June 30, 2012 | 3.498M |
| March 31, 2012 | 2.872M |
| December 31, 2011 | 2.495M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.134M
Minimum
Dec 2022
12.07M
Maximum
Mar 2021
6.095M
Average
3.661M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.8164M |
| Shareholders Equity (Quarterly) | -2.269M |
| Debt to Equity Ratio | -0.3085 |
| Current Ratio | 0.2303 |
| Net Debt Paydown Yield | -0.43% |